Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CMA
Comerica
CMA
|
+$221M |
| 2 |
RSPP
RSP Permian, Inc.
RSPP
|
+$166M |
| 3 |
Vulcan Materials
VMC
|
+$165M |
| 4 |
ANDV
Andeavor
ANDV
|
+$165M |
| 5 |
Apple
AAPL
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$251M |
| 2 |
Bank of America
BAC
|
+$225M |
| 3 |
WOOF
VCA Inc.
WOOF
|
+$214M |
| 4 |
K
Kellanova
K
|
+$188M |
| 5 |
Occidental Petroleum
OXY
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.61% |
| 2 | Technology | 11.6% |
| 3 | Healthcare | 11.38% |
| 4 | Energy | 10.68% |
| 5 | Industrials | 10.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRTX
2701
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $612K | ﹤0.01% |
117,664
-43,641
| -27% | -$239K |
|
|
GV
2702
DELISTED
Goldfield Corporation
GV
| $610K | ﹤0.01% |
+106,026
| New | +$691K |
|
|
MN
2703
DELISTED
MANNING & NAPIER, INC.
MN
| $609K | ﹤0.01% |
106,774
+85,916
| +412% | +$565K |
|
2704
Lifeway Foods
LWAY
$395M
| $608K | ﹤0.01% |
56,666
-6,706
| -11% | -$73.4K |
|
2705
Open Text
OTEX
$5.9B
| $607K | ﹤0.01% |
17,842
+8,560
| +92% | +$285K |
|
|
BBOX
2706
DELISTED
Black Box Corp
BBOX
| $605K | ﹤0.01% |
67,619
-7,607
| -10% | -$82K |
|
2707
ORIX
IX
$42.9B
| $604K | ﹤0.01% |
40,600
+21,595
| +114% | +$335K |
|
|
MDLY
2708
DELISTED
Medley Management Inc
MDLY
| $604K | ﹤0.01% |
7,281
-576
| -7% | -$54K |
|
2709
Option Care Health
OPCH
$3.54B
| $602K | ﹤0.01% |
88,578
-63,380
| -42% | -$419K |
|
|
BT
2710
DELISTED
BT Group plc (ADR)
BT
| $602K | ﹤0.01% |
29,961
-7,950
| -21% | -$166K |
|
2711
Stellus Capital Investment Corp
SCM
$247M
| $601K | ﹤0.01% |
41,300
+27,730
| +204% | +$380K |
|
|
BGB
2712
Blackstone Strategic Credit 2027 Term Fund
BGB
$501M
| $600K | ﹤0.01% |
37,868
-25,523
| -40% | -$403K |
|
2713
Eaton Vance Tax-Advantaged Dividend Income Fund
EVT
$2.17B
| $598K | ﹤0.01% |
+28,269
| New | +$608K |
|
|
GTLS
2714
DELISTED
Chart Industries
GTLS
| $598K | ﹤0.01% |
17,119
-55,389
| -76% | -$2.05M |
|
|
FUEL
2715
DELISTED
Rocket Fuel Inc.
FUEL
| $598K | ﹤0.01% |
111,530
+76,085
| +215% | +$222K |
|
2716
Alnylam Pharmaceuticals
ALNY
$32.1B
| $596K | ﹤0.01% |
11,631
-217,609
| -95% | -$10.1M |
|
2717
Digi International
DGII
$2.88B
| $596K | ﹤0.01% |
50,119
+3,188
| +7% | +$40.9K |
|
2718
Prothena Corp
PRTA
$484M
| $596K | ﹤0.01% |
10,691
-5,684
| -35% | -$299K |
|
|
BSFT
2719
DELISTED
BroadSoft, Inc.
BSFT
| $594K | ﹤0.01% |
+14,778
| New | +$629K |
|
2720
Oxford Industries
OXM
$549M
| $592K | ﹤0.01% |
10,337
-311
| -3% | -$17.2K |
|
|
POT
2721
DELISTED
Potash Corp Of Saskatchewan
POT
| $592K | ﹤0.01% |
34,674
-727,959
| -95% | -$13.2M |
|
2722
iShares MSCI Canada ETF
EWC
$6.95B
| $590K | ﹤0.01% |
21,948
+3,988
| +22% | +$108K |
|
2723
iShares US Technology ETF
IYW
$24.8B
| $588K | ﹤0.01% |
17,412
+1,628
| +10% | +$52.8K |
|
2724
Caesars Entertainment
CZR
$6.04B
| $586K | ﹤0.01% |
30,966
+13,081
| +73% | +$220K |
|
|
CVRS
2725
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $586K | ﹤0.01% |
447,255
-292,408
| -40% | -$238K |
|
Similar funds
Israel Englander's Q1 2017 Portfolio in Review
As of Q1 2017, Israel Englander held 4,184 positions worth $54.6B, up 14% from $47.8B the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.
Israel Englander deployed $4.44B of net new capital in Q1 2017, opening 894 new positions and adding to 1,327 existing holdings. Its largest new stake was Mondelez International: 3,261,215 shares worth $140M.
By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bank of New York Mellon, an estimated $251M trimmed.
- Israel Englander's largest Q1 2017 buy was Mondelez International: 3,261,215 shares worth $140M.
- Israel Englander added most to Comerica in Q1 2017, an estimated $221M increase.
- Israel Englander's biggest Q1 2017 reduction was Bank of New York Mellon, cutting an estimated $251M.
- Israel Englander fully exited Occidental Petroleum in Q1 2017, selling an estimated $171M.
- Israel Englander's ten largest holdings make up 5.7% of its $54.6B portfolio in Q1 2017.
- Israel Englander opened 894 new positions and closed 743 in Q1 2017.
- Israel Englander's portfolio value rose 14% quarter-over-quarter to $54.6B.
Based on Millennium Management's 13F filing for Q1 2017, filed 15 May 2017.